Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial

被引：4

作者：

Haddad, Fadi G. ^{[1
]}

Jabbour, Elias ^{[2
]}

Short, Nicholas J. ^{[1
]}

Jain, Nitin ^{[1
]}

Huang, Xuelin ^{[3
]}

Montalban-Bravo, Guillermo ^{[1
]}

Kadia, Tapan M. ^{[1
]}

Daver, Naval ^{[1
]}

Nasnas, Cedric ^{[1
]}

Mayor, Ejiroghene ^{[4
]}

Nasnas, Patrice Eric ^{[4
]}

Deen, Wuliamatu ^{[2
]}

Zoghbi, Marianne ^{[1
]}

Thankachan, Jennifer ^{[4
]}

Loiselle, Christopher ^{[2
]}

Garris, Rebecca ^{[1
]}

Ravandi, Farhad ^{[2
]}

Kantarjian, Hagop M. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-188064

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[1] A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).
Short, Nicholas James
Kantarjian, Hagop M.
Konopleva, Marina
Bravo, Guillermo Montalban
Ravandi, Farhad
Jain, Nitin
Kadia, Tapan M.
Valero, Yesid Alvarado
Chien, Kelly Sharon
Daver, Naval Guastad
Macaron, Walid
Sasaki, Koji
Thankachan, Jennifer
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Loiselle, Christopher
Kwari, Monica
Garris, Rebecca
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[2] A phase II trial of ponatinib and blinatumomab in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Short, Nicholas James
Jabbour, Elias
Jain, Nitin
Macaron, Walid
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval Guastad
Haddad, Fadi
Zoghbi, Marianne
Nasnas, Cedric Christophe
Nasr, Lewis Fady
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[3] Phase II study of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia
Sasaki, Koji
Kantarjian, Hagop
Konopleva, Marina
Jain, Nitin
Huang Xuelin
Ravandi, Farhad
Wierda, William
Borthakur, Gautam
Short, Nicholas
Issa, Ghayas
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
ANNALS OF ONCOLOGY, 2022, 33 : S466 - S466
[4] Ponatinib and Blinatumomab for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Subgroup Analysis from a Phase II Study
Short, Nicholas
Kantarjian, Hagop
Jain, Nitin
Huang, Xuelin
Montalban-Bravo, Guillermo
Kadia, Tapan M.
Daver, Naval
Chien, Kelly S.
Alvarado, Yesid
Garcia-Manero, Guillermo
Issa, Ghayas C.
Macaron, Walid
Haddad, Fadi
Kwari, Monica
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Thankachan, Jennifer
Loiselle, Christopher
Rivera, Juan
Milton, Anna
Waller, Lourdes
Banks, Glenda
Garris, Rebecca
Konopleva, Marina
Ravandi, Farhad
Jabbour, Elias
BLOOD, 2022, 140
[5] Blinatumomab and Ponatinib for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updated Results and Predictors of Relapse
Short, Nicholas J.
Kantarjian, Hagop
Jain, Nitin
Takahashi, Koichi
Furudate, Ken
Senapati, Jayastu
Haddad, Fadi G.
Karrar, Omer
Kadia, Tapan M.
Chien, Kelly S.
Sasaki, Koji
Kugler, Eitan
Garris, Rebecca
Ravandi, Farhad
Jabbour, Elias
BLOOD, 2024, 144 : 837 - 838
[6] Updated Results from the Phase II Study of Blinatumomab in Combination With Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Haddad, Fadi G.
Kantarjian, Hagop
Short, Nicholas J.
Konopleva, Marina
Jain, Nitin
Huang, Xuelin
Ravandi, Farhad
Wierda, William
Borthakur, Gautam
Sasaki, Koji
Issa, Ghayas
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S204 - S204
[7] Combination of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia: Early results from a phase II study.
Short, Nicholas James
Kantarjian, Hagop M.
Konopleva, Marina
Jain, Nitin
Huang, Xuelin
Ravandi, Farhad
Wierda, William G.
Borthakur, Gautam
Sasaki, Koji
Issa, Ghayas C.
Alvarado, Yesid
Pemmaraju, Naveen
Garcia-Manero, Guillermo
Thankachan, Jennifer
Garris, Rebecca
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[8] Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Ribera, Josep-Maria
Garcia-Calduch, Olga
Ribera, Jordi
Montesinos, Pau
Cano-Ferri, Isabel
Martinez, Pilar
Esteve, Jordi
Esteban, Daniel
Garcia-Fortes, Maria
Alonso, Natalia
Gonzalez-Campos, Jose
Bermudez, Arancha
Torrent, Anna
Genesca, Eulalia
Mercadal, Santiago
Martinez-Lopez, Joaquin
Garcia-Sanz, Ramon
BLOOD ADVANCES, 2022, 6 (18) : 5395 - 5402
[9] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
Couturier, Marie-Anne
Thomas, Xavier
Raffoux, Emmanuel
Huguet, Francoise
Berthon, Celine
Simand, Celestine
Gallego-Hernanz, Maria-Pilar
Hicheri, Yosr
Berger, Mathilde Hunault
Saillard, Colombe
Leguay, Thibaut
Loiseau, Clemence
Bene, Marie-Christine
Chevallier, Patrice
LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
[10] The Emerging Use of Chemotherapy-Free Regimens in Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Sawyers, Jacquelyn D.
Jammal, Nadya J.
Short, Nicholas J.
Kantarjian, Hagop
Jabbour, Elias J.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (02) : 68 - 75

← 1 2 3 4 5 →